Is there a way to be more confident
in the accuracy of conformal therapy?
It has been clearly demonstrated over the years that prostate motion over a course of treatment can jeopardize the intended outcome. In addition, the success of conformal therapy, including IMRT, requires accurate delineation of tumor volume. Low soft tissue contrast of CT imaging makes it challenging to contour target anatomy and critical structures.
Ultrasound however presents superior soft-tissue and organ boundary definition.
At time of planning, Clarity Prostate System exploits the benefits of ultrasound by combining its superior soft tissue imaging characteristics with other imaging modalities such as CT. At time of treatment, our unique, proprietary Mutual Referencing™ and assisted segmentation technologies are indispensable to achieve a high level of accuracy and speed in prostate position volume verification. They allow structure-based displacement calculations based on comparison of reference 3D structures to daily 3D structures.
Is there a way to be more confident in the delivery of conformal therapy? We believe so.